1. Home
  2. DNTH vs GCT Comparison

DNTH vs GCT Comparison

Compare DNTH & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • GCT
  • Stock Information
  • Founded
  • DNTH 2015
  • GCT 2019
  • Country
  • DNTH United States
  • GCT United States
  • Employees
  • DNTH N/A
  • GCT N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • GCT Catalog/Specialty Distribution
  • Sector
  • DNTH Health Care
  • GCT Consumer Discretionary
  • Exchange
  • DNTH Nasdaq
  • GCT Nasdaq
  • Market Cap
  • DNTH 724.8M
  • GCT 734.6M
  • IPO Year
  • DNTH N/A
  • GCT 2022
  • Fundamental
  • Price
  • DNTH $18.14
  • GCT $14.20
  • Analyst Decision
  • DNTH Strong Buy
  • GCT Strong Buy
  • Analyst Count
  • DNTH 8
  • GCT 3
  • Target Price
  • DNTH $54.33
  • GCT $36.67
  • AVG Volume (30 Days)
  • DNTH 362.0K
  • GCT 1.2M
  • Earning Date
  • DNTH 03-11-2025
  • GCT 03-03-2025
  • Dividend Yield
  • DNTH N/A
  • GCT N/A
  • EPS Growth
  • DNTH N/A
  • GCT 32.61
  • EPS
  • DNTH N/A
  • GCT 3.05
  • Revenue
  • DNTH $6,235,000.00
  • GCT $1,161,042,000.00
  • Revenue This Year
  • DNTH N/A
  • GCT $5.94
  • Revenue Next Year
  • DNTH N/A
  • GCT $15.69
  • P/E Ratio
  • DNTH N/A
  • GCT $4.66
  • Revenue Growth
  • DNTH 120.63
  • GCT 64.96
  • 52 Week Low
  • DNTH $17.50
  • GCT $13.60
  • 52 Week High
  • DNTH $32.27
  • GCT $41.31
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 36.91
  • GCT 36.29
  • Support Level
  • DNTH $17.50
  • GCT $14.51
  • Resistance Level
  • DNTH $20.45
  • GCT $16.25
  • Average True Range (ATR)
  • DNTH 1.67
  • GCT 0.73
  • MACD
  • DNTH -0.22
  • GCT 0.15
  • Stochastic Oscillator
  • DNTH 10.44
  • GCT 10.87

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc end-to-end B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.

Share on Social Networks: